U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Search Results

Semaglutide (Ozempic) Injection
Status: Currently in Shortage
»Date first posted: 08/23/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Revised 11/30/2022)

Company Contact Information:
866-696-4090 and press 0

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg / 0.5mg (NDC 0169-4132-12) Limited availability; Intermittent supply disruption will continue through January 2023 Localized short term stock outages in pharmacies Demand increase for the drug
1 mg (NDC 0169-4130-13) Currently available
2 mg (NDC 0169-4772-12) Currently available Demand increase for the drug
Back to Top